Credelio Quattro marked $100 million in net sales making it Elanco’s fastest pet health blockbuster in history and one of the industry’s fastest ever, especially with a single geographic approval ...

Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) is the first and only canine oral parasiticide to protect against six parasites, including fleas, ticks, ...

"Today is a historic day as we bring veterinarians and pet owners peace of mind with the broadest i parasite protection of its kind for dogs," said Bobby Modi, Executive Vice President, U.S. Pet ...

Please provide your email address to receive an email when new articles are posted on . Cure rates were comparable for patients with strongyloidiasis treated with either moxidectin (93.6%) or ...

Internal and external parasite threats have expanded beyond their traditional regions and seasons. Many tick species, for example, are now found in places that they didn't exist a decade ago, and they ...

GREENFIELD, Ind., Oct. 7, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced the U.S. Food and Drug Administration (FDA) has approved Credelio Quattro™ (lotilaner, ...